Xenetic Biosciences Stock Operating Margin
| XBIOWDelisted Stock | USD 17.54 0.00 0.00% |
Xenetic Biosciences fundamentals help investors to digest information that contributes to Xenetic Biosciences' financial success or failures. It also enables traders to predict the movement of Xenetic Stock. The fundamental analysis module provides a way to measure Xenetic Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xenetic Biosciences stock.
Xenetic |
Xenetic Biosciences Company Operating Margin Analysis
Xenetic Biosciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Xenetic Biosciences Operating Margin | (2.48) % |
Most of Xenetic Biosciences' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xenetic Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Xenetic Biosciences has an Operating Margin of -2.4831%. This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Xenetic Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xenetic Biosciences' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xenetic Biosciences could also be used in its relative valuation, which is a method of valuing Xenetic Biosciences by comparing valuation metrics of similar companies.Xenetic Biosciences is currently under evaluation in operating margin category among its peers.
Xenetic Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (1.83) % | |||
| Operating Margin | (2.48) % | |||
| Revenue | 2.54 M | |||
| EBITDA | (4.52 M) | |||
| Net Income | (4.13 M) | |||
| Cash And Equivalents | 2.02 M | |||
| Cash Per Share | 2.32 X | |||
| Total Debt | 809.59 K | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 1.60 X | |||
| Book Value Per Share | 5.63 X | |||
| Cash Flow From Operations | (4.11 M) | |||
| Beta | 2.3 | |||
| Total Asset | 10.61 M | |||
| Retained Earnings | (193.23 M) | |||
| Working Capital | 8.78 M | |||
| Net Asset | 10.61 M |
About Xenetic Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xenetic Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xenetic Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xenetic Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Xenetic Stock
If you are still planning to invest in Xenetic Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Xenetic Biosciences' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |